V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10342041 | 10064569 | 1.68 | null | Palliative (P) | 2017-11-29 | 2020-08-07 | Niraparib | 02 | N | BORTEZOMIB + THALIDOMIDE | 100515927 |
| 10342685 | 10064570 | null | 95.2 | null | 2021-05-01 | 2021-05-11 | Acalabrutinib | 02 | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100342117 |
| 10343318 | 10064571 | 1.91 | 0 | Palliative (P) | 2016-08-25 | 2016-08-30 | CETUXIMAB | 02 | N | VINORELBINE | 101271776 |
| 10343942 | 10064572 | 1.82 | 73.6 | null | 2019-01-21 | 2019-01-21 | Cetuximab + Radiotherapy Maint | 02 | null | BUSULFAN | 100348848 |
| 10344617 | 10064573 | 1.64 | 70 | 03 | 2019-03-26 | 2021-06-22 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | FLUOROURACIL | 101711570 |
| 10344706 | 10064574 | 1.82 | 68 | Adjuvant (A) | 2016-08-16 | 2022-01-28 | Azacitidine | 02 | N | AZACITIDINE | 100229239 |
| 10344794 | 10064575 | 1.68 | 76.4 | 03 | 2020-06-27 | 2020-08-01 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 101238011 |
| 10344832 | 10064576 | 1.66 | 77.3 | Palliative (P) | 2018-07-20 | 2018-07-28 | Palbociclib | 02 | N | PALBOCICLIB | 101849123 |
| 10344995 | 10064577 | 1.91 | 93.4 | null | 2018-11-11 | 2018-11-13 | Methotrexate intrathecal | 2 | null | METHOTREXATE | 100687509 |
| 10345100 | 10064578 | 1.78 | null | null | 2021-05-17 | 2021-05-17 | BORTEZOMIB + THALIDOMIDE | 02 | null | VINORELBINE | 100052207 |
| 10345183 | 10064579 | 1.79 | 79.2 | Palliative (P) | 2021-12-27 | 2021-12-27 | AFATINIB | 02 | N | AFATINIB | 101118914 |
| 10345985 | 10064580 | 1.71 | 78.1 | Neo-adjuvant (N) | 2019-10-17 | 2019-10-18 | Niraparib | 02 | N | BORTEZOMIB + THALIDOMIDE | 101854550 |
| 10346155 | 10064581 | 1.72 | null | Adjuvant (A) | 2019-05-04 | 2019-05-11 | Niraparib | 02 | N | IPILIMUMAB + NIVOLUMAB | 101144118 |
| 10347359 | 10064582 | 1.85 | 79.3 | Palliative (P) | 2018-04-19 | 2018-04-19 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100215681 |
| 10347573 | 10064583 | 1.79 | 51.1 | 03 | 2021-08-29 | 2021-08-29 | Cisplatin 7 day | 02 | N | VINORELBINE | 101175252 |
| 10347790 | 10064584 | null | 75.6 | Palliative (P) | 2020-06-09 | 2020-06-09 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 100122337 |
| 10348764 | 10064585 | 1.7 | 90.1 | null | 2022-02-02 | 2022-02-13 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | null | CISPLATIN | 100430393 |
| 10349266 | 10064586 | null | 73.3 | Not known (9) | 2019-03-12 | 2019-07-24 | Melphalan IV High dose | 02 | N | MELPHALAN | 101278660 |
| 10350156 | 10064587 | 1.71 | 114 | Adjuvant (A) | 2019-03-16 | 2019-03-16 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101707494 |
| 10354576 | 10064591 | 1.62 | 73.7 | null | 2020-03-02 | 2020-03-02 | Azacitidine | 02 | null | AZACITIDINE | 101148300 |
| 10354581 | 10064592 | 1.77 | 85.7 | null | 2018-04-27 | 2018-05-10 | null | 02 | null | DABRAFENIB | 100820369 |
| 10355267 | 10064593 | 1.68 | 66 | Palliative (P) | 2018-11-11 | 2018-11-11 | Carboplatin + Vinorelbine IV &PO D8 | 02 | N | CARBOPLATIN + VINORELBINE | 101637425 |
| 10355560 | 10064594 | null | 94 | Palliative (P) | 2022-01-09 | 2022-01-15 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | NIRAPARIB | 101498072 |
| 10356446 | 10064595 | 1.58 | 68.8 | null | 2018-11-12 | 2018-12-28 | Chlorambucil | 02 | null | CHLORAMBUCIL | 101175884 |
| 10356697 | 10064596 | 1.72 | 68 | null | 2020-07-24 | 2020-09-07 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101738276 |
| 10358907 | 10064599 | null | 70.3 | 03 | 2019-06-28 | 2019-07-16 | Palbociclib | 02 | N | PALBOCICLIB | 100331139 |
| 10359193 | 10064600 | 1.68 | 49.3 | Palliative (P) | 2022-02-08 | 2022-02-18 | Bortezomib | 02 | N | BORTEZOMIB | 100567201 |
| 10359234 | 10064601 | 1.55 | 77.8 | Palliative (P) | 2019-03-16 | 2019-03-17 | null | 02 | N | NIRAPARIB | 100270520 |
| 10359341 | 10064602 | 1.68 | 70 | Palliative (P) | 2022-01-04 | 2022-01-24 | Cisplatin + Vinorelbine (IV) | 02 | N | FLUOROURACIL | 101705819 |
| 10359394 | 10064603 | 1.73 | 82 | Adjuvant (A) | 2017-03-12 | 2017-04-09 | null | 02 | N | BUSULFAN | 100636537 |
| 10361328 | 10064605 | 1.56 | 68.4 | Palliative (P) | 2022-04-11 | 2022-04-24 | Cisplatin | 02 | N | CABOZANTINIB | 100029162 |
| 10361548 | 10064606 | 1.72 | 65 | 03 | 2021-11-16 | 2021-12-06 | VINORELBINE | 02 | N | BUSULFAN | 100295419 |
| 10362682 | 10064607 | 1.51 | 71.6 | Palliative (P) | 2021-08-10 | 2022-01-29 | Capecitabine (21 day) + Irinotecan | 02 | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 100323336 |
| 10363855 | 10064608 | 1.85 | 74.9 | Palliative (P) | 2018-11-21 | 2021-12-24 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101583433 |
| 10364497 | 10064610 | 1.78 | 59.8 | null | 2021-02-02 | 2021-02-12 | Melphalan IV High dose | 02 | null | MELPHALAN | 101325769 |
| 10364764 | 10064611 | 1.6 | 80.7 | Neo-adjuvant (N) | 2018-08-17 | 2018-09-03 | null | 02 | N | DABRAFENIB | 101416604 |
| 10364994 | 10064612 | 1.57 | 70 | 03 | 2020-04-03 | 2020-05-20 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | IPILIMUMAB + NIVOLUMAB | 100866053 |
| 10365670 | 10064615 | 1.7 | null | null | 2021-10-18 | 2021-10-18 | Acalabrutinib | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101222193 |
| 10365977 | 10064616 | 1.55 | 99.3 | Palliative (P) | 2022-03-02 | 2022-03-04 | MELPHALAN | 02 | N | MELPHALAN | 101150206 |
| 10367063 | 10064618 | 1.77 | 62 | 03 | null | 2021-05-31 | Chlorambucil | 02 | N | CHLORAMBUCIL | 100261662 |
| 10367828 | 10064622 | 1.56 | 99 | Neo-adjuvant (N) | 2020-01-12 | 2020-01-19 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 101414832 |
| 10367882 | 10064623 | 1.79 | 80 | 03 | 2020-06-21 | 2020-06-28 | PERTUZUMAB + TRASTUZUMAB | 02 | N | FLUOROURACIL | 100594389 |
| 10368044 | 10064624 | 1.69 | 63.5 | null | 2020-02-17 | 2020-02-17 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100186007 |
| 10368315 | 10064627 | 1.77 | 78 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CISPLATIN + GEMCITABINE | 100683518 |
| 10368801 | 10064630 | 1.64 | 70.3 | Palliative (P) | 2019-05-30 | 2019-06-01 | CABOZANTINIB | 02 | N | BUSULFAN | 101799038 |
| 10368858 | 10064631 | 1.88 | 63 | null | 2019-06-21 | 2019-06-21 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 101322649 |
| 10369028 | 10064632 | 1.53 | 63 | Curative (C) | 2019-11-08 | 2019-11-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100358720 |
| 10369039 | 10064633 | 1.5 | 68 | null | 2019-01-12 | 2019-01-12 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101055997 |
| 10369060 | 10064634 | 1.72 | 58 | Palliative (P) | 2020-09-26 | 2021-01-13 | AFATINIB | 02 | N | AFATINIB | 101710990 |
| 10369153 | 10064635 | 1.75 | 84.6 | Palliative (P) | 2017-06-28 | 2018-04-19 | Niraparib | 02 | N | CABOZANTINIB | 100332133 |